Press Releases – The Ä¢¹½ÊÓƵ Group Global Website – Eat Well, Live Well. The Ä¢¹½ÊÓƵ group is a leading global company with the specialties in the business of food and amino acids, guided by our leading-edge bioscience and fine chemical technologies. Tue, 18 Nov 2025 04:03:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 Notice Concerning the Status and Program Completion of Repurchase of Own Shares[English Disclosure Information] /media/pressreleases/notice-concerning-the-status-and-program-completion-of-repurchase-of-own-sharesenglish-disclosure-information Tue, 18 Nov 2025 06:30:32 +0000 /?post_type=pressreleases&p=50860 Ä¢¹½ÊÓƵ Co., Inc. and Forge Biologics Develops Culture Media Supplements to Improve Productivity of Gene Therapy Products /media/pressreleases/ajinomoto-co-inc-and-forge-biologics-develops-culture-media-supplements-to-improve-productivity-of-gene-therapy-products Fri, 14 Nov 2025 05:00:01 +0000 /?post_type=pressreleases&p=50851 Consolidated Financial Results for the Six Months Ended September 30, 2025[English Disclosure Information] /media/pressreleases/consolidated-financial-results-for-the-six-months-ended-september-30-2025english-disclosure-information Thu, 06 Nov 2025 06:32:24 +0000 /?post_type=pressreleases&p=50838 Notice Concerning Determination of Matters Related to Repurchase of Own Shares[English Disclosure Information] /media/pressreleases/notice-concerning-determination-of-matters-related-to-repurchase-of-own-sharesenglish-disclosure-information Thu, 06 Nov 2025 06:30:28 +0000 /?post_type=pressreleases&p=50836 Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information] /media/pressreleases/notice-concerning-progress-on-repurchase-of-own-sharesenglish-disclosure-information-6 Wed, 05 Nov 2025 06:30:55 +0000 /?post_type=pressreleases&p=50824 Ä¢¹½ÊÓƵ Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology /media/pressreleases/ajinomoto-co-inc-enters-licensing-agreement-with-astellas-pharma-inc-for-biopharmaceutical-development-and-manufacturing-technology Fri, 31 Oct 2025 06:30:38 +0000 /?post_type=pressreleases&p=50814 Ä¢¹½ÊÓƵ Co., Inc. Files Patent Infringement Suits in China and Japan Regarding Its Manufacturing Process for Monosodium Glutamate (MSG) Products /media/pressreleases/ajinomoto-co-inc-files-patent-infringement-suits-in-china-and-japan-regarding-its-manufacturing-process-for-monosodium-glutamate-msg-products Tue, 14 Oct 2025 05:00:33 +0000 /?post_type=pressreleases&p=50673 Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information] /media/pressreleases/notice-concerning-progress-on-repurchase-of-own-sharesenglish-disclosure-information-5 Thu, 02 Oct 2025 06:30:42 +0000 /?post_type=pressreleases&p=50658 Notice Concerning Progress on Repurchase of Own Shares[English Disclosure Information] /media/pressreleases/notice-concerning-progress-on-repurchase-of-own-sharesenglish-disclosure-information-4 Tue, 02 Sep 2025 06:30:32 +0000 /?post_type=pressreleases&p=50508 Ä¢¹½ÊÓƵ Co., Inc. to Build a New Factory at Ä¢¹½ÊÓƵ Philippines Corporation /media/pressreleases/ajinomoto-co-inc-to-build-a-new-factory-at-ajinomoto-philippines-corporation Thu, 28 Aug 2025 05:00:34 +0000 /?post_type=pressreleases&p=50415